Other
Metabolic Acidosis
6
Pipeline Programs↗
2
Active Trials↗
6
Companies Involved↗
Metabolic Acidosis is an early-stage landscape with 6 programs across 6 companies. The most active players are POLYSAN Scientific & Technological Pharmaceutical Company, Dawnrays Pharmaceutical (Holdings) Limited, Novartis. 2 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical1
Phase 1
No programs
Phase 23
Approved
No programs
Analysis
Trial Status
5
clinical trials
Completed3 · 60%
Recruiting1 · 20%
Active, not recruiting1 · 20%
Clinical Trials
Trial Activity
Meglimine Sodium Succinate for Correction of Metabolic Acidosis in Critically Ill Patients
Completed·PPOLYSAN Scientific & Technological Pharmaceutical Company·Phase 2·NCT05147051·140 enrolled
Prevention of Metabolic Acidosis in Preterm Neonates by Replacing Sodium Chloride With Sodium Acetate in Parenteral Nutrition
Recruiting·—·Phase 3·NCT06545565·200 enrolled
SODium BICarbonate for Metabolic Acidosis in the ICU
Active, not recruiting·—·Phase 3·NCT05697770·500 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)